![]() |
Autoimmune Disorders |
Free Subscription
1 Brain |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Autoimmune Disorders is free of charge.
Models of autoantibody mediated diseases: actively nearing the human gold
standard.
Brain. 2025 May 23:awaf160. doi: 10.1093.
PubMed
The intestinal microbiome in type 1 diabetes: bridging early childhood exposures
with translational advances.
Curr Opin Immunol. 2025;94:102553.
PubMed
Abstract available
A UK healthcare professional survey on the islet autoantibody status of children
and young people with pre-stage 3 type 1 diabetes, on behalf of the British
Society for Paediatric Endocrinology and Diabetes.
Diabet Med. 2025 May 23:e70069. doi: 10.1111/dme.70069.
PubMed
Establishing the performance and acceptability of dried blood spot sampling to
screen for islet-specific autoantibodies.
Diabet Med. 2025 May 19:e70071. doi: 10.1111/dme.70071.
PubMed
Abstract available
Soluble HLA Class I Is Released From Human beta-Cells Following Exposure to
Interferons.
Diabetes. 2025;74:956-968.
PubMed
Abstract available
Reduced Function of the Adaptor SH2B3 Promotes T1D via Altered
Cytokine-Regulated, T-Cell-Intrinsic Immune Tolerance.
Diabetes. 2025;74:943-955.
PubMed
Abstract available
Regulation of Type 1 Diabetes via Brown Adipocyte-Secreted Proteins and the Novel
Glucagon Regulator Nidogen-2.
Diabetes. 2025 Feb 28:db241003. doi: 10.2337/db24-1003.
PubMed
Abstract available
Intermittent Low-Magnitude Pressure Applied Across Macroencapsulation Devices
Enables Physiological Insulin Delivery Dynamics.
Diabetes. 2025;74:873-884.
PubMed
Abstract available
Type 1 diabetes depends on CD4-driven expression of the transcriptional
repressor, Bcl6.
Diabetes. 2024 Nov 18:db230709. doi: 10.2337/db23-0709.
PubMed
Abstract available
The Effect of Small Increases in Blood Glucose on Insulin Secretion and
Endogenous Glucose Production in Humans.
Diabetes. 2025;74:898-906.
PubMed
Abstract available
The automated correction index (ACI), a novel report-derived metric correlated to
glucose control and variability in patients with type 1 diabetes on advanced
hybrid closed loop therapy.
Diabetes Res Clin Pract. 2025;224:112173.
PubMed
Abstract available
Corneal confocal microscopy identifies early and definite diabetic cardiac
autonomic neuropathy.
Diabetes Res Clin Pract. 2025;224:112172.
PubMed
Abstract available
Making Sense: Feasibility of an education program to Empower adults with type 1
diabetes to interpret CGM data.
Diabetes Res Clin Pract. 2025;224:112171.
PubMed
Abstract available
Comparison of the association between COVID-19 and new onset diabetes in a
regional and national dataset.
Diabetes Res Clin Pract. 2025;224:112190.
PubMed
Abstract available
Impact of continuous moderate-intensity aerobic exercise on glycemic control
according to different phases of the menstrual cycle in females with type 1
diabetes.
Diabetes Res Clin Pract. 2025;224:112192.
PubMed
Abstract available
SCI - U: Validation of an updated Self-Care Inventory for contemporary diabetes
management in adolescents with type 1 diabetes.
Diabetes Res Clin Pract. 2025;224:112218.
PubMed
Abstract available
Effect of vitamin D supplementation on glycemic control in children and
adolescents with type 1 diabetes mellitus: Data from a controlled clinical trial.
Diabetes Res Clin Pract. 2025;224:112210.
PubMed
Abstract available
Development and validation of a scale measuring perceived barriers to physical
activity in Spanish for children and adolescents with type 1 diabetes: the
Physical Activity Barriers Scale for pediatric type 1 diabetes (PABS-1)
questionnaire.
Diabetes Res Clin Pract. 2025;224:112223.
PubMed
Abstract available
Diagnostic performance of graded tuning fork vibration thresholds as a
stand-alone test and within clinical assessments of diabetic neuropathy.
Diabetes Res Clin Pract. 2025;224:112224.
PubMed
Abstract available
Periodontal disease in adolescents with type 1 diabetes mellitus: A cross link
between continuous glucose monitoring-derived metrics, caspase-3 levels, diabetic
nephropathy and subclinical atherosclerosis.
Diabetes Res Clin Pract. 2025;224:112234.
PubMed
Abstract available
Paediatric screening in Italy as a gateway to secondary prevention in type 1
diabetes.
Diabetes Res Clin Pract. 2025;224:112233.
PubMed
Abstract available
Continuous glucose monitoring as equinox of nocturnal and daytime hypoglycaemia
in type 1 diabetes: insights from the randomized controlled HypoDE trial.
Diabetes Res Clin Pract. 2025;224:112228.
PubMed
Abstract available
High-Throughput Proteomics and Immunohistochemistry of Orbital Connective Tissue
in Graves' Orbitopathy.
J Clin Endocrinol Metab. 2025 May 21:dgaf299. doi: 10.1210.
PubMed
Abstract available
Greater urinary calcium excretion is associated with diminished bone accrual in
youth with type 1 diabetes.
J Clin Endocrinol Metab. 2024 Sep 20:dgae660. doi: 10.1210.
PubMed
Abstract available
Discrimination and precision of Continuous Glucose Monitoring in staging children
with presymptomatic type 1 diabetes.
J Clin Endocrinol Metab. 2024 Oct 16:dgae691. doi: 10.1210.
PubMed
Abstract available
Soluble Immune Checkpoints Associated With Disease Activity and Treatment
Response in GD and TED.
J Clin Endocrinol Metab. 2025;110:1537-1549.
PubMed
Abstract available
Approach to Lipid Management in the Patient with Diabetes.
J Clin Endocrinol Metab. 2025 Jan 11:dgaf018. doi: 10.1210.
PubMed
Abstract available
Biomarkers, Proteoforms, and Mass Spectrometry-based Assays for Diabetes Clinical
Research.
J Clin Endocrinol Metab. 2025 Mar 8:dgaf159. doi: 10.1210.
PubMed
Abstract available
The Type 1 Diabetes Genetics Consortium (T1DGC).
J Clin Endocrinol Metab. 2025 Mar 21:dgaf181. doi: 10.1210.
PubMed
Abstract available
Mice deficient of G-protein coupled receptor 3 (GPR3) developed severe
experimental autoimmune uveitis (EAU) through increased effector T cell
activities.
J Immunol. 2025 May 17:vkaf099. doi: 10.1093.
PubMed
Abstract available
Associations between serum levels of alpha-calcitonin gene-related peptide and
clinical features of neuromyelitis optica spectrum disorders.
J Neuroimmunol. 2025;404:578615.
PubMed
Abstract available
MOGAD optic neuritis after mild head/orbital trauma in six children.
J Neuroimmunol. 2025;404:578605.
PubMed
Abstract available
Recurrent anti-NMDA receptor encephalitis in first-trimester pregnancy with
initially antibody-negative CSF.
J Neuroimmunol. 2025;404:578602.
PubMed
Abstract available
Real-world observational study of infections in people treated with ocrelizumab
for multiple sclerosis.
J Neurol. 2025;272:415.
PubMed
Abstract available
Relapses during treatment with monoclonal antibodies targeting B-cells in NMOSD.
J Neurol. 2025;272:406.
PubMed
Abstract available
Effects of exercise on balance function in people with multiple sclerosis: a
systematic review and meta-analysis of randomized controlled trials.
J Neurol. 2025;272:405.
PubMed
Abstract available
Beyond EDSS: multidomain impairments are detectable and associated with walking
disorders in low-disabled people with multiple sclerosis.
J Neurol. 2025;272:404.
PubMed
Abstract available
Fluctuations in serum aquaporin-4 antibody titers: the clinical significance in
neuromyelitis optica spectrum disorder.
J Neurol. 2025;272:403.
PubMed
Abstract available
Health care use preceding pediatric multiple sclerosis: A population-based study
from Ontario, Canada.
Mult Scler. 2025 May 23:13524585251338745. doi: 10.1177/13524585251338745.
PubMed
Abstract available
Smoking status and vascular risk factors as predictors of disability in
AQP4-NMOSD and MOGAD.
Mult Scler. 2025;31:658-667.
PubMed
Abstract available
Incidence and prevalence of neuromyelitis optica spectrum disorder in a
contemporary, multi-ethnic cohort.
Mult Scler. 2025;31:642-657.
PubMed
Abstract available
Safety and tolerability of conversion to siponimod from other disease-modifying
therapies in patients with advancing forms of relapsing MS: Results from the
EXCHANGE study.
Mult Scler. 2025;31:706-718.
PubMed
Abstract available
AI-assisted identification of disability patterns within identical EDSS grades.
Mult Scler. 2025;31:677-688.
PubMed
Abstract available
Anti-beta2GPI/beta2GPI complex promotes thrombosis by activating the P2Y2/MAPKs pathway
to increase human neutrophil peptides.
PLoS One. 2025;20:e0322447.
PubMed
Abstract available
Validation of a data-driven multicomponent T2 analysis for quantifying myelin
content in the cuprizone mouse model of multiple sclerosis.
PLoS One. 2025;20:e0323614.
PubMed
Abstract available
Validation of retroactively derived T1 relaxation values from 3D T1-weighted
images with clinical and MRI measures of disability in multiple sclerosis.
PLoS One. 2025;20:e0323898.
PubMed
Abstract available
Safety and efficacy of antigen-specific therapeutic approaches for multiple
sclerosis: Systematic review.
PLoS One. 2025;20:e0320814.
PubMed
Abstract available
Urinary MCP-1 and VCAM-1 as non-invasive biomarkers for the diagnosis and
activity assessment of lupus nephritis.
PLoS One. 2025;20:e0323334.
PubMed
Abstract available
Sex-chromosome complement and Activin-A shape the therapeutic potential of TNFR2
activation in a model of MS and CNP.
Proc Natl Acad Sci U S A. 2025;122:e2426771122.
PubMed
Abstract available
Immune perturbation by the ileal microbiota in multiple sclerosis.
Proc Natl Acad Sci U S A. 2025;122:e2506777122.
PubMed
Targeting the Aryl Hydrocarbon Receptor to Attenuate IGF1R Signaling in Thyroid
Eye Disease.
Thyroid. 2025 Apr 21. doi: 10.1089/thy.2024.0529.
PubMed
Abstract available
Thank you for your interest in scientific medicine.